Greenland Mines Ltd. (NASDAQ: GRML) has released an independent Initial Assessment (IA) for its Sarfartoq Nd-Pr Rare Earth Element Project in southwest Greenland, revealing a high-case pre-tax net present value (NPV) of up to approximately $2.05 billion at an 8% real discount rate, with an internal rate of return (IRR) of 118.6%. The assessment, which includes Indicated and Inferred Mineral Resources, also outlines a more conservative scenario excluding Inferred resources, yielding a pre-tax NPV of up to $1.49 billion and an IRR of 92.7%.
The IA is based on the ST1 deposit, which occupies less than 1% of the company's 191-square-kilometer exploration license. The project is planned as a nine-year mining operation processing 12.2 million tons at an annual rate of 1.4 million tons. At 2025 consumption levels, the planned Sarfartoq NdPr oxide production would account for approximately 34% of NdPr oxide refined outside China during each scheduled operating year, underscoring its strategic importance in the global rare earth supply chain.
Greenland Mines noted that five other known rare earth occurrences within the license remain largely untested, and the company plans to initiate additional exploration beginning in September 2026. Further work includes targeted infill drilling, pilot-scale metallurgical test work, mine engineering planning, and continued environmental and social baseline studies as the project advances toward a Pre-Feasibility Study.
The announcement is significant for the critical minerals sector, as Western nations and companies seek to reduce dependence on Chinese rare earth processing. The Sarfartoq project's potential to supply a substantial share of non-Chinese NdPr oxide could enhance supply chain resilience and support the transition to electric vehicles and renewable energy technologies, which rely heavily on rare earth magnets.
For investors, the high IRR and NPV figures suggest strong economic potential, though these are preliminary estimates subject to further study and refinement. The IA provides a foundational view of the project's value, but the company must still navigate technical, regulatory, and market risks before development.
Greenland Mines is a Nasdaq-listed company with two operating divisions: Mining, focused on the Skaergaard Project and the Sarfartoq rare earths project (subject to closing of a previously announced transaction), and Biotech, including Klotho's KLTO-202 primary indication for ALS. The company's strategy is to build a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision.
The full press release can be viewed at https://ibn.fm/7uEG4. Latest news and updates on GRML are available at https://ibn.fm/GRML.
